Changes in Bruxism Activity After Periodontal Treatment in Patients With Periodontitis
NCT ID: NCT07053878
Last Updated: 2025-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2025-06-27
2025-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-surgical Periodontal Therapy: Efficacy of re Treatment for Non-responding Sites.
NCT05297227
Assessment of Tooth Mobility After Non-surgical Periodontal Treatment Followed by Tooth Splinting
NCT06929676
Evaluation of Periodontal Response to Non Surgical Therapy in Pre and Post Menopausal Women With Periodontitis
NCT02718014
Diode Laser and SRP in Chronic Periodontitis
NCT02407379
Periodontal Treatment in Non Smokers, Former Smokers and Smokers
NCT04061460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Periodontitis Group
Participants with Stage III or IV periodontitis will receive full non-surgical periodontal therapy (step 1 and step 2), along with standardized oral hygiene instructions and motivation. Bruxism activity and periodontal status will be assessed at baseline and after three months.
Non-Surgical Periodontal Therapy (Step 1 & 2)
Comprehensive supra- and sub-gingival instrumentation (scaling, root planing, ultrasonic and manual instruments), following EFP step-1 and step-2 protocols. Includes individualized oral-hygiene instruction and motivation.
Healthy Control Group
Periodontally healthy participants will receive supragingival plaque removal and polishing, along with standardized oral hygiene instructions and motivation. Bruxism activity and periodontal status will be assessed at baseline and after three months.
Supragingival Plaque Removal and Polishing
Professional supragingival scaling with ultrasonic tips plus rubber-cup polishing in a single session. Includes the same individualized oral-hygiene instruction and motivation provided to the experimental group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Surgical Periodontal Therapy (Step 1 & 2)
Comprehensive supra- and sub-gingival instrumentation (scaling, root planing, ultrasonic and manual instruments), following EFP step-1 and step-2 protocols. Includes individualized oral-hygiene instruction and motivation.
Supragingival Plaque Removal and Polishing
Professional supragingival scaling with ultrasonic tips plus rubber-cup polishing in a single session. Includes the same individualized oral-hygiene instruction and motivation provided to the experimental group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good general health (ASA I or II)
* Signed informed consent
* Willingness to attend all study visits and follow instructions
* For periodontitis group: diagnosis of Stage III or IV periodontitis according to the 2017 classification
* For healthy control group: no clinical signs of periodontitis
Exclusion Criteria
* Antibiotic or anti-inflammatory therapy within the last 3 months
* Periodontal treatment in the last 6 months
* Smoking more than 10 cigarettes/day
* Use of occlusal splints or bruxism-targeted therapy in the past 6 months
* Pregnancy or lactation
* Any condition impairing the ability to cooperate or comply with the study protocol
25 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Siena
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicola Discepoli
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicola Discepoli, DDS, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Medical Biotechnologies, University of Siena
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AOUS
Siena, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PB002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.